Eneti Says President Of Co Purchased 25K Shares At Average Price Of $8.64/Share

Eneti Inc. (NYSE:NETI) (the "Company") announced today that the President of the Company, Robert Bugbee, has recently purchased 25,000 common shares of the Company at an average price of $8.64 per

byBenzinga Newsdesk

November 17, 2021

1 minute read

Eneti Inc. (NYSE:NETI) (the “Company”) announced today that the President of the Company, Robert Bugbee, has recently purchased 25,000 common shares of the Company at an average price of $8.64 per share in the open market.

Keybanc Maintains Overweight on Bentley Systems, Raises Price Target to $65

By Benzinga Newsdesk

Today, 9:06 PM

Keybanc analyst Jason Celino maintains Bentley Systems (NASDAQ:BSY) with a Overweight and raises the price target from $60 to $65.

BSY

Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Stitch Fix Shares Slide

By Lisa Levin

Today, 9:06 PM

Toward the end of trading Wednesday, the Dow traded down 0.08% to 35,692.63 while the NASDAQ rose 0.45% to 15,757.04. The S&P also rose, gaining 0.12% to 4,692.41.

NVEI

Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target

By Benzinga Newsdesk

Today, 9:06 PM

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target.

RNA

Universal Health Services Q3 Adj. EPS $2.67 Misses $2.75 Estimate, Sales $3.16B Beat $3.10B Estimate

By Benzinga Newsdesk

Today, 9:06 PM

Universal Health Services (NYSE:UHS) reported quarterly earnings of $2.67 per share which missed the analyst consensus estimate of $2.75 by 2.91 percent. This is a 7.29 percent decrease over earnings of $2.88 per share

UHS

Eneti Says President Of Co Purchased 25K Shares At Average Price Of $8.64/Share

Related Posts

Keybanc Maintains Overweight on Bentley Systems, Raises Price Target to $65

Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Stitch Fix Shares Slide

Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target

Universal Health Services Q3 Adj. EPS $2.67 Misses $2.75 Estimate, Sales $3.16B Beat $3.10B Estimate